Results 111 to 120 of about 53,102 (149)
Some of the next articles are maybe not open access.
European Journal of Clinical Investigation, 1994
Abstract.The evidence in support of the safety and efficacy of aspirin in the secondary prevention of platelet dependent vascular occlusion is compelling. The utility of this drug has stalled the development of potential competitors, such as thromboxane antagonists.
G A, Fitzgerald, E A, Meagher
openaire +3 more sources
Abstract.The evidence in support of the safety and efficacy of aspirin in the secondary prevention of platelet dependent vascular occlusion is compelling. The utility of this drug has stalled the development of potential competitors, such as thromboxane antagonists.
G A, Fitzgerald, E A, Meagher
openaire +3 more sources
Medical Journal of Australia, 1999
Antiplatelet drugs protect against myocardial infarction, stroke, cardiovascular death and other serious vascular events in patients with a history of previous vascular events or known risk factors for cardiovascular disease. Aspirin reduces the risk of serious vascular events in patients at high risk of such an event by about a quarter and is ...
R I, Baker, G J, Hankey
openaire +3 more sources
Antiplatelet drugs protect against myocardial infarction, stroke, cardiovascular death and other serious vascular events in patients with a history of previous vascular events or known risk factors for cardiovascular disease. Aspirin reduces the risk of serious vascular events in patients at high risk of such an event by about a quarter and is ...
R I, Baker, G J, Hankey
openaire +3 more sources
Antiplatelet drug nonresponsiveness
American Heart Journal, 2008The response to most medication, including antiplatelet drugs, is highly variable between individuals. Observational studies have shown that nonresponders to antiplatelet agents appear to have an increased incidence of vascular events. This review article reviews the background, mechanisms, and evidence in support of the clinical significance of this ...
Patrick, Gladding +4 more
openaire +2 more sources
Differential Effect of Omega-3 Fatty Acids on Platelet Inhibition by Antiplatelet Drugs In Vitro [PDF]
International Journal of Molecular SciencesDespoina Pantazi +2 more
exaly +2 more sources
Aspirin as an Antiplatelet Drug
New England Journal of Medicine, 1994The past 10 years have witnessed major changes in our understanding of the pathophysiologic mechanisms underlying vascular occlusion1,2 and considerable progress in the clinical assessment of aspirin and other antiplatelet agents3–5. The purpose of this review is to describe a rational basis for antithrombotic prophylaxis and treatment with aspirin ...
Alastair J.J. Wood, Carlo Patrono
openaire +2 more sources
Antiplatelet drugs: Potential therapeutic options for the management of neurodegenerative diseases
Medicinal Research Reviews, 2023Sunil K Singh +2 more
exaly
Anticoagulant and antiplatelet drugs
Catheterization and Cardiovascular Interventions, 2001openaire +2 more sources
Perspective on Antiplatelet Drugs
Seminars in Thrombosis and Hemostasis, 1989openaire +2 more sources